Immunotherapy of cancer beyond checkpoint inhibitors

CaixaForum Madrid, 16th and 17th of December 2024

EVENT WILL START IN
  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Add to My Calendar 2024-12-16 08:30:00 2024-12-17 18:00:00 Europe/Madrid <strong>Immunotherapy of cancer beyond checkpoint inhibitors</strong> Gather is a responsive event theme with many awesome features including add to my calendar feature. Awesome. huh? Madrid, España Clínica Universidad de Navarra / CIMA info@cancerimmunotherapyday-cun.com

FULL PROGRAM

Registration

09.45 - 10.20

Welcome

Ignacio Melero
10.20 - 10.30

Session 1

Chair Pedro Berraondo López

Opening Keynote Lecture: «Understanding and exploiting immunogenic cell death»

Guido Kroemer- Centre de Recherche des Cordeliers, France.
 
10.30 - 10.50

Q&A

10.50 - 11.00

«Microbiota and cancer immunotherapy»

Laurence Zitvogel- Institut Gustave Roussy, France.
11.00 - 11.20

Q&A

11.20 - 11.30

«Cancer Immunotherapy: Teaching old dogs new tricks»

Ignacio Melero Bermejo – CIMA / CUN, Spain
11.30 – 11.50

Q&A

11.50 - 12.00

Session 2

Chair María Rodríguez Ruiz

«Targeting cancer related immune suppression by vaccination»

 Inge Marie Svane- National Center for Cancer Immunotherapy, Denmark
12.00- 12.20

Q&A

12.20 - 12.30

«Immune synapses as immunotherapy targets»

Michael Dustin- University of Oxford, UK
12.30 - 12.50

Q&A

12.50 - 13.00

«New targetable immunosuppressive factors».

 Marisol Soengas- CNIO, Spain
13.00 - 13.20

Q&A

13.20 - 13.30

Buffet type LUNCH

13.30 - 15.00

Session 3

Chair Antonio González

«Colon cancer immunotherapy”

Luis Diaz- Memorial Sloan Kettering Cancer Center, USA
15.00 - 15.20

Q&A

15.20 - 15.30

«Neoadjuvant immunotherapy for MSI colon cancer»

Myriam Chalabi- Netherlands Cancer Institute, Netherlands
15.30 - 15.50

Q&A

15.50 - 16.00

«Neoadjuvant immunotherapy of lung cancer «

Mariano Provencio- IDIPHIM, Spain
16.00 - 16.20

Q&A

16.20 - 16.30

Break

16.30 - 17.00

Session 4

Chair Miguel F. Sanmamed

«The myeloid tumor microenvironment: opportunities for intervention»

 Miriam Merad- Icahn School of Medicine at Mount Sinai, USA
17.00 - 17.20

Q&A

17.20 - 17.30

«Immunosuppressive cytokines in cancer immunology and immunotherapy»

Joan Seoane- VHIO, Spain
17.30 - 17.50

Q&A

17.50 - 18.00

«How industry and academia should collaborate»

 Antoni Ribas- UCLA, USA
18.00 - 18.20

Q&A

18.20 - 18.30

«Improving T-Cell transfer strategies”

 Sebastian Kobold- Klinikum der Universität München, Germany
18.30 - 18.50

Q&A

18.50 - 19.00

Session 5

Chair Juanjo Lasarte

«Mechanisms of NK cells in cancer immunotherapy

Miguel López-Botet- University Pompeu Fabra (UPF)-Hospital del Mar
Research Institute (IMIM), Spain
09.00 - 09.20

Q&A

09.20 - 09.30

«On TILs and neoantigens»

Alena Gros- VHIO, Spain
09.30 - 09.50

Q&A

09.50 - 10.00

«Adrenergic control of antitumor immunity»

Benoit Van den Eynde- University of Oxford, UK
10.00 – 10.20

Q&A

10.20 - 10.30

Break

10.30 - 11.00

Session 6

Chair Fernando Aranda Vega

«TCRs recognizing shared oncogenic mutations»

Iñaki Etxeberria- Memorial Sloan Kettering Cancer Center, USA
11.00 – 11.20

Q&A

11.20 - 11.30

«Modeling and modulating antitumor immunity in human cancer tissues”

Daniela Thommen- Netherlands Cancer Institute, Netherlands
11.30 – 11.50

Q&A

11.50 - 12.00

«Chimeric proteins to unleash antitumor immunity «

Closing Keynote Lecture: Pablo Umaña, Switzerland
12.00 - 12.20

Q&A

12.20 - 12.30

 Meeting Adjourns Ignacio Melero

12.30 - 13.00

EVENT SUPPORTED BY

Bristol-Myers_Squibb_logo
bioncotech
Agenus Logo (PRNewsFoto/Agenus Inc.)
Astrazeneca-CancerInmunotherapyDay

Pfizer

email-icon

CONTACT

Clínica Universidad de Navarra / CIMA
Cibeles Pinto

mcpinto@unav.es

+34 948194700 x 814012

ADDRESS

CaixaForum Madrid

P.º del Prado, 36,
28014 Madrid, Spain.

Time: 9:00 AM to 20:00 PM. Monday to Sunday.

back to top